Invitation: Roche’s Virtual IR Digitalization Day Freitag, 08. November 2024 - 10:08

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 25 November 2024, showcasing how computation biology and AI/ML/LLM get integrated into early drug discovery and drug development following the "lab in a loop" concept.

Speaker
Aviv Regev, Head of Genentech Research and Early Development (gRED)

16:30 - 18:00 CET / 15:30 - 17:00 GMT
10:30 am - 12:00 pm EST / 7:30 - 9:00 am PST

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CET on the day of the event. >click here

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Jon Bayard
Investor Relations Officer

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com